Vivo Opportunity Fund Holdings, L.P. - 31 Jan 2025 SCHEDULE 13G/A Report for Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (TERN)

Filing Manager: Vivo Opportunity Fund Holdings, L.P.
Reporting Manager: Vivo Opportunity Fund Holdings, L.P.
Security: Terns Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share
Symbol: TERN
Shares outstanding: 108,024,600 shares
Disclosed Ownership: 2,700,615 shares
Ownership: 2.5%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2026, 18:11:57 UTC
Date of event: 31 Jan 2025
SEC: View on sec.gov

Reporting Managers (7)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Vivo Capital Fund VIII, L.P.	0.9%	966,461	966,461	/s/ Frank Kung	Frank Kung/Managing Member of Vivo Capital VIII, LLC, General Partner
Vivo Capital Surplus Fund VIII, L.P.	0.1%	133,415	133,415	/s/ Frank Kung	Frank Kung/Managing Member of Vivo Capital VIII, LLC, General Partner
Vivo Capital VIII, LLC	1%	1,099,876	1,099,876	/s/ Frank Kung	Frank Kung/Managing Member
Vivo Opportunity Fund Holdings, L.P.	2.5%	2,700,615	2,700,615	/s/ Kevin Dai	Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC	2.5%	2,700,615	2,700,615	/s/ Kevin Dai	Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P.	0.2%	241,652	241,652	/s/ Kevin Dai	Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC	0.2%	241,652	241,652	/s/ Kevin Dai	Kevin Dai/Managing Member